IPSEY saw its Momentum Indicator move below the 0 level on December 17, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 102 similar instances where the indicator turned negative. In of the 102 cases, the stock moved further down in the following days. The odds of a decline are at .
The 50-day moving average for IPSEY moved below the 200-day moving average on December 10, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPSEY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for IPSEY entered a downward trend on December 02, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IPSEY's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where IPSEY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IPSEY just turned positive on December 03, 2024. Looking at past instances where IPSEY's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
IPSEY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.783) is normal, around the industry mean (57.958). P/E Ratio (23.474) is within average values for comparable stocks, (89.727). Projected Growth (PEG Ratio) (5.417) is also within normal values, averaging (2.947). Dividend Yield (0.010) settles around the average of (0.122) among similar stocks. P/S Ratio (2.901) is also within normal values, averaging (19.472).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IPSEY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPSEY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
Industry PharmaceuticalsOther
A.I.dvisor tells us that IPSEY and LBTSF have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEY and LBTSF's prices will move in lockstep.
Ticker / NAME | Correlation To IPSEY | 1D Price Change % | ||
---|---|---|---|---|
IPSEY | 100% | -0.74% | ||
LBTSF - IPSEY | 15% Poorly correlated | N/A | ||
LVRLF - IPSEY | 9% Poorly correlated | -13.04% | ||
HYPMY - IPSEY | 7% Poorly correlated | -7.83% | ||
IPSEF - IPSEY | 6% Poorly correlated | N/A | ||
INDV - IPSEY | 5% Poorly correlated | -2.87% | ||
More |